ARCHIBUGI, LIVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.853
EU - Europa 1.851
AS - Asia 1.828
SA - Sud America 285
Continente sconosciuto - Info sul continente non disponibili 167
AF - Africa 29
OC - Oceania 1
Totale 6.014
Nazione #
US - Stati Uniti d'America 1.737
RU - Federazione Russa 1.142
SG - Singapore 632
CN - Cina 630
IT - Italia 262
BR - Brasile 236
HK - Hong Kong 175
VN - Vietnam 125
BD - Bangladesh 116
SE - Svezia 91
DE - Germania 86
FR - Francia 72
GB - Regno Unito 61
CA - Canada 60
FI - Finlandia 44
IN - India 39
MX - Messico 30
AR - Argentina 19
JP - Giappone 19
PL - Polonia 19
NL - Olanda 17
AT - Austria 16
TR - Turchia 15
ZA - Sudafrica 14
IQ - Iraq 11
ES - Italia 10
ID - Indonesia 10
IL - Israele 8
PK - Pakistan 8
SA - Arabia Saudita 7
CO - Colombia 6
JM - Giamaica 6
MY - Malesia 6
PH - Filippine 6
UA - Ucraina 6
BE - Belgio 5
CR - Costa Rica 5
EC - Ecuador 5
VE - Venezuela 5
BO - Bolivia 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
EG - Egitto 3
HN - Honduras 3
IE - Irlanda 3
LT - Lituania 3
MD - Moldavia 3
TH - Thailandia 3
TN - Tunisia 3
UZ - Uzbekistan 3
BG - Bulgaria 2
CH - Svizzera 2
DK - Danimarca 2
GT - Guatemala 2
GY - Guiana 2
KE - Kenya 2
KZ - Kazakistan 2
MA - Marocco 2
NI - Nicaragua 2
PE - Perù 2
SR - Suriname 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
ML - Mali 1
MV - Maldive 1
NP - Nepal 1
PA - Panama 1
PY - Paraguay 1
SV - El Salvador 1
ZW - Zimbabwe 1
Totale 5.847
Città #
Singapore 347
Moscow 229
Ashburn 223
San Jose 194
Hong Kong 172
Dallas 163
Shanghai 112
Beijing 102
Council Bluffs 91
New York 83
Milan 72
Los Angeles 64
Hefei 58
Ho Chi Minh City 46
Lauterbourg 45
Santa Clara 38
Nuremberg 36
Phoenix 35
Boardman 33
São Paulo 29
Hanoi 27
Munich 27
Montreal 23
Orem 23
Rome 22
Turku 22
Washington 21
Chennai 19
Tokyo 18
Princeton 17
Brooklyn 16
Lawrence 16
Houston 15
Atlanta 14
Lappeenranta 14
Warsaw 14
Brescia 12
Johannesburg 12
London 12
Mexico City 12
Bergamo 11
Guangzhou 11
Shenzhen 11
Bologna 10
Denver 10
Rio de Janeiro 10
Toronto 10
Chicago 9
Poplar 9
Stockholm 9
Barnet 8
Buffalo 8
Cesano Boscone 8
Helsinki 8
Salvador 8
Seattle 8
The Dalles 8
Vienna 8
Florence 7
Frankfurt am Main 7
San Francisco 7
Boston 6
Dhaka 6
Jakarta 6
Manchester 6
Naples 6
Querétaro 6
Amsterdam 5
Brussels 5
Calgary 5
Carlsbad 5
Columbus 5
Miami 5
New Delhi 5
Orlando 5
Philadelphia 5
Tel Aviv 5
The Bronx 5
Wuxi 5
Ankara 4
Brasília 4
Bến Tre 4
Cagliari 4
Charlotte 4
City of London 4
Curitiba 4
Fortaleza 4
Jiaxing 4
Kingston 4
Las Vegas 4
Middletown 4
Mountain View 4
Porto Alegre 4
Ribeirão Preto 4
Riyadh 4
San José 4
Santa Fe 4
Baghdad 3
Caracas 3
Caxias do Sul 3
Totale 2.890
Nome #
Genetic and non-genetic risk factors for early-onset pancreatic cancer 159
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 151
Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer 150
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 143
A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma 135
DIAGNOSTIC DELAY AT DIAGNOSIS AND TIME-TO-TREATMENT INFLUENCE OVERALL SURVIVAL OF PANCREATIC CANCER PATIENTS 129
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 129
ENDOSCOPY-BASED INVESTIGATION OF NOVEL BIOMARKERS FOR PANCREATIC CANCER 127
Needle-Tract Seeding of Pancreatic Cancer after EUS-FNA: A Systematic Review of Case Reports and Discussion of Management 126
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer 124
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 124
Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study 123
Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women. 123
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 120
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery 116
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 116
EUS-Guided Anti-tumor Therapy: Ablation of Solid Neoplasms 115
EUS-Guided Choledocho-duodenostomy Using Lumen Apposing Stent Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Biliary Obstruction: A Multicenter Randomized Controlled Trial (DRA-MBO Trial) 112
Managing complications of chronic pancreatitis: a guide for the gastroenterologist 111
Early onset pancreatic cancer. Risk factors, presentation and outcome 109
Diagnosis and treatment in chronic pancreatitis: an international survey and case vignette study 107
Chronic use of statins and acetylsalicylic acid and incidence of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: A multicenter, prospective, cohort study 105
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features 100
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer 99
Risk factors for the occurrence of ampullary tumors: A case-control study 97
Alcohol and gastrointestinal cancers 97
Chronic use of statins and aminosalicylic acid and incidence of post-ERCP acute pancreatitis. Preliminary data from the STARK study, a prospective international, multicenter, cohort study 96
Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk 95
Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer 92
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction 92
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 92
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma 87
High sensitivity of ROSE-supported ERCP-guided brushing for biliary strictures 87
EUS diagnostic puncture 86
Exocrine pancreatic insufficiency in diabetic patients. prevalence, mechanisms, and treatment 84
The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals 84
FEASIBILITY OF ORAL AND DUODENAL MICROBIOTA ANALYSIS OF PANCREATIC CANCER PATIENTS AND CONTROLS 79
Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization 77
Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk 77
Same-session endoscopic diagnosis and symptom palliation in pancreato-biliary malignancies: Clinical impact of rapid on-site evaluation (ROSE) 76
Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility 76
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk 75
The baseline nutritional status assessed by MUST score has a low accuracy in predicting the risk of hospitalization during follow-up in patients with chronic pancreatitis: A cohort study: CP nutritional status and complications 74
Present and Future of Local Therapies for Unresectable Pancreatic Cancer 74
Multidrug-resistant bacterial colonization affects postoperative outcomes after pancreaticoduodenectomy 72
Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study 71
Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk 70
Systematic review and meta-analysis. small intestinal bacterial overgrowth in chronic pancreatitis 69
A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma 68
Gynecological and reproductive factors and the risk of pancreatic cancer. a case-control study 68
P.04.12 ROLE OF CYST FEATURES AND PATIENTS' FACTORS IN PREDICTING THE RISK OF PROGRESSION IN BD-IPMN UNDERGOING FOLLOW-UP 68
How to do EUS - guided Ablation of Pancreatic Neurendocrine Tumors 67
Standardization of a Radiofrequency Ablation Tool in an Ex-Vivo Porcine Liver Model 66
Slow-pull compared to suction technique for EUS-guided sampling of pancreatic solid lesions: a meta-analysis of randomized controlled trials 66
Machine learning for the prediction of post-ERCP Pancreatitis risk: A proof-of-concept study 64
Role of endoscopic ultrasound in the age of personalized medicine 62
EUS-guided gastroenterostomy in a COVID-19-infected patient with duodenal stenosing lymphoma (with videos) 61
Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis 60
Genome-wide association study identifies an early onset pancreatic cancer risk locus 60
EUS-guided drainage of Post-Surgical versus Post-Pancreatitis collections (the RESPELL study): A prospective comparison of clinical presentations and therapeutic outcomes 56
Infection Control Practices and Outcomes of Endoscopy Units in the Lombardy Region of Italy: A Survey From the Italian Society of Digestive Endoscopy During COVID-19 Spread 56
Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk 53
P.04.4 PRESENTATION SYMPTOMS AND RISK FACTORS ARE ASSOCIATED WITH DIAGNOSTIC DELAY AND DISEASE STAGE BUT NOT WITH SURVIVAL OF PATIENTS WITH PANCREATIC CANCER 51
Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreatic Cancer 41
Paired Duodenal and Salivary Microbiome Analysis in Pancreatic Cancer Without Duct Obstruction 32
Clinical usefulness of scoring systems to predict severe acute pancreatitis: A systematic review and meta-analysis with pre and post-test probability assessment 20
Correlation between endoscopic ultrasound features and exocrine pancreatic function in chronic pancreatitis 16
Cost–effectiveness of pancreatic cancer screening: Time for a more tailored approach 12
Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians 11
Endoscopic ultrasound-guided gallbladder drainage in acute cholecystitis with contained perforation: a prospective cohort study 9
Primary drainage of distal malignant biliary obstruction: A comparative network meta-analysis 8
How to approach indeterminate biliary stenosis 7
Totale 6.014
Categoria #
all - tutte 26.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202250 0 0 0 6 8 0 1 1 7 27 0 0
2022/2023148 35 30 14 4 5 19 6 18 3 0 11 3
2023/2024385 34 19 42 34 39 69 18 37 5 6 24 58
2024/20251.012 78 29 34 41 93 99 161 93 158 62 74 90
2025/20263.820 243 198 190 400 351 127 308 302 1.089 259 161 192
2026/2027582 286 287 9 0 0 0 0 0 0 0 0 0
Totale 6.014